Search by Drug Name or NDC

NDC 00409-4759-01 Ondansetron 2 mg/mL Details

Ondansetron 2 mg/mL

Ondansetron is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is ONDANSETRON HYDROCHLORIDE.

MedlinePlus Drug Summary

Ondansetron injection is used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Related Packages: 00409-4759-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ondansetron Injection

Product Information

NDC	00409-4759
Product ID	0409-4759_7fe1d355-dc6e-443b-9b19-4dc27e115375
Associated GPIs	50250065052030
GCN Sequence Number	015869
GCN Sequence Number Description	ondansetron HCl VIAL 2 MG/ML INTRAVEN
HIC3	H6J
HIC3 Description	ANTIEMETIC/ANTIVERTIGO AGENTS
GCN	20011
HICL Sequence Number	006055
HICL Sequence Number Description	ONDANSETRON HCL
Brand/Generic	Generic
Proprietary Name	Ondansetron
Proprietary Name Suffix	n/a
Non-Proprietary Name	ONDANSETRON
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	INTRAMUSCULAR; INTRAVENOUS
Active Ingredient Strength	2
Active Ingredient Units	mg/mL
Substance Name	ONDANSETRON HYDROCHLORIDE
Labeler Name	Hospira, Inc.
Pharmaceutical Class	Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA077473
Listing Certified Through	2024-12-31

Package

NDC 00409-4759-01 (00409475901)

Pricing Information	N/A
NDC Package Code	0409-4759-01
Billing NDC	00409475901
Package	1 VIAL, MULTI-DOSE in 1 CARTON (0409-4759-01) / 20 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date	2006-11-07
NDC Exclude Flag	N